Comparison of 3D Phase-Sensitive Inversion-Recovery and 2D Inversion-Recovery MRI at 3.0 T for the Assessment of Late Gadolinium Enhancement in Patients with Hypertrophic Cardiomyopathy

Academic Radiology

Volumn 20, Issue 6, 2013, Pages 752-757

  Morita, Kosuke ^a,b   Utsunomiya, Daisuke ^a   Oda, Seitaro ^a   Komi, Masanori ^b   Namimoto, Tomohiro ^a   Hirai, Toshinori ^a   Hashida, Masahiro ^b   Takashio, Seiji ^a   Yamamuro, Megumi ^a   Yamashita, Yasuyuki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hypertrophic cardiomyopathy; Late gadolinium enhancement; Magnetic resonance imaging; Phase sensitive inversion recovery

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; BREATH HOLDING; BREATHING MECHANICS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE QUALITY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PHASE SENSITIVE INVERSION RECOVERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUSCEPTIBILITY WEIGHTED IMAGING; TWO DIMENSIONAL INVERSION RECOVERY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84877597785     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2013.01.014     Document Type: Article

References (28)

1. Mahrholdt H., Wagner A., Judd R.M., et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005, 26:1461-1474.
2. Maron B.J., McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003, 24:1965-1991.
3. Gersh B.J., Maron B.J., Bonow R.O., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 124:e783-e831.
4. Nael K., Fenchel M., Saleh R., et al. Cardiac MR imaging: new advances and role of 3T. Magn Reson Imaging Clin North Am 2007, 15:291-300. v.
5. Araoz P.A., Glockner J.F., McGee K.P., et al. 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson 2005, 7:559-564.
6. Maron B.J., Gardin J.M., Flack J.M., et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995, 92:785-789.
7. Ho C.Y., Lopez B., Coelho-Filho O.R., et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. New Engl J Med 2010, 363:552-563.
8. Shirani J., Pick R., Roberts W.C., et al. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 2000, 35:36-44.
9. Adabag A.S., Maron B.J., Appelbaum E., et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369-1374.
10. Monserrat L., Elliott P.M., Gimeno J.R., et al. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. J Am Coll Cardiol 2003, 42:873-879.
11. Christiaans I., van Engelen K., van Langen I.M., et al. Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: systematic review of clinical risk markers. Europace 2010, 12:313-321.
12. Adabag A.S., Casey S.A., Kuskowski M.A., et al. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. J Am Coll Cardiol 2005, 45:697-704.
13. Kim R.J., Judd R.M. Gadolinium-enhanced magnetic resonance imaging in hypertrophic cardiomyopathy: in vivo imaging of the pathologic substrate for premature cardiac death?. J Am Coll Cardiol 2003, 41:1568-1572.
14. Bruder O., Wagner A., Jensen C.J., et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:875-887.
15. Kellman P., Larson A.C., Hsu L.Y., et al. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med 2005, 53:194-200.
16. Kellman P., Arai A.E., McVeigh E.R., et al. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002, 47:372-383.
17. Cerqueira M.D., Weissman N.J., Dilsizian V., et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002, 105:539-542.
18. Dietrich O., Raya J.G., Reeder S.B., et al. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. J Magn Reson Imaging 2007, 26:375-385.
19. Moon J.C., Reed E., Sheppard M.N., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004, 43:2260-2264.
20. Greenbaum R.A., Ho S.Y., Gibson D.G., et al. Left ventricular fibre architecture in man. Br Heart J 1981, 45:248-263.
21. Kuribayashi T., Roberts W.C. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 1992, 70:1333-1340.
22. Kino A., Keeling A.N., Farrelly C.T., et al. Assessment of left ventricular myocardial scar in infiltrative and non-ischemic cardiac diseases by free breathing three dimensional phase sensitive inversion recovery (PSIR) TurboFLASH. Int J Cardiovasc Imaging 2011, 27:527-537.
23. Peukert D., Laule M., Taupitz M., et al. 3D and 2D delayed-enhancement magnetic resonance imaging for detection of myocardial infarction: preclinical and clinical results. Acad Radiol 2007, 14:788-794.
24. Ozgun M., Maintz D., Bunck A.C., et al. Right atrial scar detection after catheter ablation: comparison of 2D and high spatial resolution 3D-late enhancement magnetic resonance imaging. Acad Radiol 2011, 18:488-494.
25. Sorajja P., Chareonthaitawee P., Ommen S.R., et al. Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy. Am Heart J 2006, 151:426-435.
26. Kaimoto S., Kawasaki T., Kuribayashi T., et al. Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2011, 28:1829-1839.
27. Hashimoto J., Ogawa K., Kubo A., et al. Application of transmission scan-based attenuation compensation to scatter-corrected thallium-201 myocardial single-photon emission tomographic images. Eur J Nucl Med 1998, 25:120-127.
28. Prvulovich E.M., Lonn A.H., Bomanji J.B., et al. Effect of attenuation correction on myocardial thallium-201 distribution in patients with a low likelihood of coronary artery disease. Eur J Nucl Med 1997, 24:266-275.